日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

尼沃单抗和伊匹单抗治疗复发或难治性原发性不明癌症:一项 II 期临床试验

Maria Pouyiourou #, Bianca N Kraft #, Timothy Wohlfromm, Michael Stahl, Boris Kubuschok, Harald Löffler, Ulrich T Hacker, Gerdt Hübner, Lena Weiss, Michael Bitzer, Thomas Ernst, Philipp Schütt, Thomas Hielscher, Stefan Delorme, Martina Kirchner, Daniel Kazdal, Markus Ball, Klaus Kluck, Albrecht Sten

Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

靶向BET蛋白可下调miR-33a,从而促进其与PIM抑制剂在CMML中的协同作用。

Christopher T Letson ,Maria E Balasis ,Hannah Newman ,Moritz Binder ,Alexis Vedder ,Fumi Kinose ,Markus Ball ,Traci Kruer ,Ariel Quintana ,Terra L Lasho ,Christy M Finke ,Luciana L Almada ,Jennifer M Grants ,Guolin Zhang ,Martin E Fernandez-Zapico ,Alexandre Gaspar-Maia ,Jeffrey Lancet ,Rami Komrokji ,Eric Haura ,David A Sallman ,Gary W Reuther ,Aly Karsan ,Uwe Rix ,Mrinal M Patnaik ,Eric Padron

Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes

慢性粒单核细胞白血病祖细胞层级揭示了与不良预后相关的炎症性单核细胞偏向性发展轨迹

Meghan C Ferrall-Fairbanks # ,Abhishek Dhawan # ,Brian Johnson ,Hannah Newman ,Virginia Volpe ,Christopher Letson ,Markus Ball ,Anthony M Hunter ,Maria E Balasis ,Traci Kruer ,Nana Adjoa Ben-Crentsil ,Jodi L Kroeger ,Robert Balderas ,Rami S Komrokji ,David A Sallman ,Jing Zhang ,Rafael Bejar ,Philipp M Altrock # ,Eric Padron #

Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML

细胞因子的异质性表达导致 CMML 的临床多样性并改善预后

Sandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, Samer Sansil, Anthony D Pomicter, Maria E Balasis, John Robinson, Jodi Kroeger, Qing Zhang, Yu Long Zhao, Markus Ball, Rami Komrokji, Alan List, Michael W Deininger, Brooke L Fridley, Valeria Santini, Eric Solary, Eric Padron